University Research Contributes £45 Billion a Year to the UK Economy, According to new Impact Study
News Mar 15, 2010
The data, which are being presented at a British Academy / Economic Sciences Research Council innovation seminar today (Tuesday 16 March), also suggest that benefits of research spending in higher education are greater than those from other areas of government-supported research and development (R&D).
"£45 billion a year is a good return on £3.5 billion," says economist Professor Haskel, co-author of the study from Imperial College Business School. "It's important to be able to put a proper figure on how public investment in university research correlates with private sector productivity for the first time."
The authors used 20 years' worth of figures from the Department for Business, Innovation and Skills to construct a new measure called private sector total factor productivity (TFP), which is the change in output not accounted for by typical forms of spending, such as labour and machinery investment. The TFP figures calculated in this study capture the contribution of 'intangible' activities such as new technology, knowledge, skills and design, for the first time. The study shows a strong correlation between public spend on research (through the research councils) and increased TFP over 21 years (1986-2007).
There are two main challenges to working out how university research contributes to productivity. "First, universities openly publish new findings and make them freely available for use anywhere in the economy, so it's hard to follow a payment trail from idea to application," explains Professor Haskel. "Second, the private sector also invests in developing new knowledge, so we also need to account for these investments before looking at effects from universities."
The study also shows that the benefits of public spending on research in higher education are greater than those from other R&D areas supported by government, such as publicly funded civil and defence R&D, which show no such correlations with private sector growth.
This research was funded by the COINVEST project from the European Commission Seventh Framework Programme (Theme 9: Socio-economic Science and Humanities).
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.